This is an updated assessment of the risks associated with the Zika virus epidemic in affected countries, EU Overseas Countries and Territories, and Outermost Regions and in EU Member States within continental Europe.
The latest update of ECDC’s rapid risk assessment on the Zika epidemic includes an assessment of the level of risk for travellers based on an adaptation of the WHO interim guidance on the Zika virus country classification scheme and the recent epidemiological and scientific information.
This scientific advance presents relevant scientific literature and outlines the main findings from Zika virus research published between 19 October 2016
ECDC recognises that although the intensity and scale of expansion of the Zika outbreak is slowing, Zika virus remains of significant concern as recognised by WHO.
This update of ECDC’s rapid risk assessment on the Zika epidemic considers the recent epidemiological and scientific information in light of the risk to Europe and European citizens.
ECDC comment on the preliminary report by de Araújo et al. of a case-control study aiming to test the hypothesis of the association between the occurrence of microcephaly and Zika virus.
This eighth update assesses the risks associated with the Zika virus epidemic currently affecting countries in the Americas. It provides updated information for those travelling to and returning from affected countries and for EU citizens residing in areas with active transmission. It reviews available information on the association between Zika virus infection and congenital central nervous system malformations, including microcephaly, as well as the association between Zika virus infection and Guillain–Barré syndrome. It also proposes a range of mitigation measures for EU/EEA Member States to consider.
This summary aims to outline the main findings with regard to Zika virus research published between the rapid risk assessment of 12 July 2016) and 19 August 2016.